1. 243P Skin biopsies for pharmacodynamic studies of tebentafusp: A novel bispecific molecule against the melanocytic antigen gp100. (December 2022) Authors: Stäger, R.; Tastanova, A.; Ramelyte, E.; Levesque, M.P.; Dummer, R.; Meier-Schiesser, B. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cutaneous squamous cell carcinomas on special locations: perioral, periocular and genital area. (13th December 2019) Authors: Nägeli, M.C.; Ramelyte, E.; Dummer, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33(2019)Supplement 8 Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Developments in targeted therapy in melanoma. Issue 3 (March 2017) Authors: Amann, V.C.; Ramelyte, E.; Thurneysen, S.; Pitocco, R.; Bentele-Jaberg, N.; Goldinger, S.M.; Dummer, R.; Mangana, J. Journal: European journal of surgical oncology Issue: Volume 43:Issue 3(2017:Mar.) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Histiocytosis – cutaneous manifestations of hematopoietic neoplasm and non‐neoplastic histiocytic proliferations. (31st January 2018) Authors: Luder, C.M.; Nordmann, T.M.; Ramelyte, E.; Mühleisen, B.; Kerl, K.; Guenova, E.; Dummer, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 6(2018) Page Start: 926 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. How to break resistance to hedgehog inhibitors in advanced basal cell carcinoma?. (1st February 2021) Authors: Ramelyte, E.; Restivo, G.; Imhof, L.; Nägeli, M.C.; Dummer, R. Journal: British journal of dermatology Issue: Volume 184:Number 2(2021) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. How to break resistance to hedgehog inhibitors in advanced basal cell carcinoma?. (28th December 2020) Authors: Ramelyte, E.; Restivo, G.; Imhof, L.; Nägeli, M.C.; Dummer, R. Journal: British journal of dermatology Issue: Volume 184:Number 2(2021) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Oestrogen receptor expression in melanoma. (14th September 2017) Authors: Ramelyte, E.; Koelblinger, P.; Dummer, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 9(2017) Page Start: 1399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Taking daylight‐PDT home. (28th March 2019) Authors: Ramelyte, E.; Imhof, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 4(2019) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Unmasking of a primary desmoplastic melanoma tumour in the course of treatment of a metastatic disease with anti‐PD‐1 monoclonal antibody. (26th May 2019) Authors: Richtig, G.; Ramelyte, E.; Koch, L.; Greinix, H.; Ferrone, S.; Dummer, R.; Richtig, E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 10(2019) Page Start: e381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗